<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-19T11:26:46+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！贝达药业「恩莎替尼」获批上市，首个国产 ALK 抑制剂</title>
    <updated>2020-11-19T10:13:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/0hgU1C642cvchNKkFC0LLQ</id>
    <link href="https://mp.weixin.qq.com/s/0hgU1C642cvchNKkFC0LLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，9 款仿制药过评，6 个为首家，3 个注射剂</title>
    <updated>2020-11-19T10:13:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/i6eBBi2_qFEmiR8UTWL-iA</id>
    <link href="https://mp.weixin.qq.com/s/i6eBBi2_qFEmiR8UTWL-iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江药业「恩替卡韦口服溶液」首仿获批</title>
    <updated>2020-11-19T10:13:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/UJhhSusEjvhkZTWh_MLztg</id>
    <link href="https://mp.weixin.qq.com/s/UJhhSusEjvhkZTWh_MLztg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞近一个月已有 12 款新药获批临床，「医药一哥」威力不减</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/Ps_xUXKHUoRh8W3YOp8YxA</id>
    <link href="https://mp.weixin.qq.com/s/Ps_xUXKHUoRh8W3YOp8YxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>针对 NSCLC，百济神州 PD-1 全球关键性 III 期临床达主要终点</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/KB4AjM78E_cm0I9You8fsw</id>
    <link href="https://mp.weixin.qq.com/s/KB4AjM78E_cm0I9You8fsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物 c-Met 靶向 ADC 国内首次获批临床</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/_30CvOQ01SC2dJ2Fe6zi6A</id>
    <link href="https://mp.weixin.qq.com/s/_30CvOQ01SC2dJ2Fe6zi6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1.7 亿美元引进！先声药业 CDK4/6 抑制剂递交临床申请</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/lTsx646v46eOhYs3NJ8SpA</id>
    <link href="https://mp.weixin.qq.com/s/lTsx646v46eOhYs3NJ8SpA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东抗病毒药「来特莫韦」国内首报上市</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/npcgPaJ-trv2ngBP2gjkCQ</id>
    <link href="https://mp.weixin.qq.com/s/npcgPaJ-trv2ngBP2gjkCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迈瑞医疗：集采对公司业务基本无影响</title>
    <updated>2020-11-18T18:30:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/59JRg2Xbn8cpAKHxfMYXRA</id>
    <link href="https://mp.weixin.qq.com/s/59JRg2Xbn8cpAKHxfMYXRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这 43 个新药，获批临床了</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/zqb0nhGRMUgqIu_Pl0clsQ</id>
    <link href="https://mp.weixin.qq.com/s/zqb0nhGRMUgqIu_Pl0clsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Insight 策划 | 生物药研发策略沙龙下周二苏州见！</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/pNnPqVTUuDpF1mkGyPRIIw</id>
    <link href="https://mp.weixin.qq.com/s/pNnPqVTUuDpF1mkGyPRIIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10 亿重磅注射剂！华东医药「注射用泮托拉唑钠」过评</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/v7A2w48CYzxuPXEdR8RnJQ</id>
    <link href="https://mp.weixin.qq.com/s/v7A2w48CYzxuPXEdR8RnJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 CDK4/6 抑制剂获批临床</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/SVq9UTfLEsXurtzvLn1RqQ</id>
    <link href="https://mp.weixin.qq.com/s/SVq9UTfLEsXurtzvLn1RqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>94.5% 有效率！Moderna 公司 mRNA 新冠疫苗新进展</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/gU_gYLYi-HlihBPBXzz2Ag</id>
    <link href="https://mp.weixin.qq.com/s/gU_gYLYi-HlihBPBXzz2Ag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业 SIM1803-1A 启动临床</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/P6CsVMvE6V6AAeGxliQyeQ</id>
    <link href="https://mp.weixin.qq.com/s/P6CsVMvE6V6AAeGxliQyeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企授权交易频繁，国内药企研发实力日益获得国际认可</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Dw4QVojibUf38U_EdiE9pg</id>
    <link href="https://mp.weixin.qq.com/s/Dw4QVojibUf38U_EdiE9pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州 HER2 双抗今日获批临床，拟于 2021 上半年登陆科创板，首家三地上市</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/vNtzv52Lcwh_4bca8-h8zQ</id>
    <link href="https://mp.weixin.qq.com/s/vNtzv52Lcwh_4bca8-h8zQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 SHR-1314 单抗获批临床</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/fSziEPF8_9bXzj7NyJNtUg</id>
    <link href="https://mp.weixin.qq.com/s/fSziEPF8_9bXzj7NyJNtUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【本周四】2020药品上市许可持有人（MAH）政策解读与生产许可证申请实施培训</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/xyqeS1M11lUN7Xo2ZMIkUA</id>
    <link href="https://mp.weixin.qq.com/s/xyqeS1M11lUN7Xo2ZMIkUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年 10 月 CDE 药品审评报告</title>
    <updated>2020-11-14T12:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/qyOpE3xIdzaBRh_s7qSFQg</id>
    <link href="https://mp.weixin.qq.com/s/qyOpE3xIdzaBRh_s7qSFQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>